-
1 week ago | 
healio.com | Raj Chovatiya |Erin Michael |Carol L. DiBerardino
In this video, Raj Chovatiya, MD, PhD, discusses updates on oral therapies in psoriasis from the American Academy of Dermatology Annual Meeting. “We saw updates largely in the oral therapeutic realm, even more so than the biologic therapeutic realm,” Chovatiya, who is a clinical associate professor for Chicago Medical School at Rosalind Franklin University and assistant clinical professor at George Washington University School of Health Sciences, said.
-
1 week ago | 
healio.com | Gabrielle Capaldo |Carol L. DiBerardino |Heather Rogers |Susan Taylor
Key takeaways: The U.S. has not seen the approval of a new sunscreen ingredient since the 1990s. The FDA’s plan to phase out animal testing removes one of the obstacles standing between Americans and new sunscreens. The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of certain drugs, which could have implications for the approval of new sunscreen ingredients in the United States.
-
1 week ago | 
healio.com | Sara Kellner |Carol L. DiBerardino
Key takeaways: IL-6 levels peak 6 hours after infection, compared with 24 hours for traditional biomarkers. The biomarker was an effective early indicator of sepsis in children and pregnant women. VIENNA —Interleukin-6 could help physicians diagnose sepsis early in children and pregnant women, according to a real-world study presented at the ESCMID Global meeting 2025.
-
1 week ago | 
healio.com | Gabrielle Capaldo |Carol L. DiBerardino
Key takeaways: Overall, 84.1% and 70.5% of patients treated with icotrokinra achieved IGA 0 or 1 and PASI 90, respectively, by week 16. No new safety signals were identified. New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press release.
-
1 week ago | 
healio.com | Sara Kellner |Carol L. DiBerardino
Key takeaways: More than 3 million children died from AMR-associated complications in 2022. The use of watch and reserve antibiotics rose significantly from 2019 to 2021. VIENNA — More than 3 million children died from antimicrobial resistance-associated complications in 2022 across the globe, most of whom lived in Southeast Asia and Africa, according to findings presented at ESCMID Global 2025.
-
1 week ago | 
healio.com | Carol L. DiBerardino
Key takeaways: Tremfya is an interleukin-23 inhibitor being evaluated for the treatment of psoriatic arthritis. Twenty-four-week results showed Tremfya reduced signs, symptoms and structural progression of the disease. Editor’s note: This is a developing news story. Please check back soon for updates. Tremfya reduced signs and symptoms of psoriatic arthritis, as well as progression of structural damage, according to new phase 3 results.
-
2 weeks ago | 
healio.com | Sara Kellner |Carol L. DiBerardino
Key takeaways:Children with sleep-disordered breathing had lower health care use after tonsil removal. Those who had surgery had fewer skin- or pain-related conditions, likely because of decreased inflammation. Surgical removal of the adenoids and tonsils reduced the number of health care visits and prescriptions for children with mild sleep-disordered breathing compared with watchful waiting, a study found.
-
2 weeks ago | 
healio.com | Regina Schaffer |Carol L. DiBerardino
Key takeaways:Autistic women reported heightened sensory sensitivities during menopause that disrupted daily life. Clinicians must provide clear, accessible information on perimenopause tailored to autistic people’s needs. Autistic women can face unique challenges during the menopause transition, especially when it comes to navigating sensory challenges and interactions with clinicians as they seek to address their symptoms.
-
2 weeks ago | 
healio.com | Gabrielle Capaldo |Carol L. DiBerardino
April 10, 2025 2 min read Additional dose of rituximab may shorten rates of pemphigus relapse Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Immunology in Dermatology. Subscribe You've successfully added Immunology in Dermatology to your alerts. You will receive an email when new content is published. Click Here to Manage Email AlertsBack to Healio We were unable to process your request.
-
2 weeks ago | 
healio.com | Regina Schaffer |Carol L. DiBerardino |Jeanne Conry
Key takeaways:Global maternal mortality declined 40% between 2000 and 2023 as access to health care improved. The pace of improvement has slowed since 2016 and humanitarian funding cuts may further hamper progress. Women are more likely than ever to survive pregnancy today because of global improvements in infrastructure and access to care, but researchers caution humanitarian funding cuts could reverse any large public health gains.
